Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Chandrasekhar Bal

18PUBLICATIONS
3CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyMolecular targetsPredictive and prognostic markersChild and adolescent development
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

Sort by Publication Date:
|Jun 25, 2026
Long-term outcomes in medullary thyroid cancer patients treated with [<sup>177</sup>Lu]Lu-DOTAGA.FAPi dimer therapy.

|Feb 04, 2025
Low-Dose Versus High-Dose Lenvatinib in Radioiodine Refractory Differentiated Thyroid Cancer-A Real-World Safety and Efficacy Analysis.

Jeepalem Sai Moulika, Kunal Ramesh Chandekar, Shubha Gadde Ravindra

|Mar 12, 2024
[<sup>177</sup>Lu]Lu-PSMA-617 as first-line systemic therapy in patients with metastatic castration-resistant prostate cancer: a real-world study.

Swayamjeet Satapathy, Madhav Prasad Yadav, Sanjana Ballal

|Jan 12, 2024
Optimal Cumulative I-131 Activity in Metastatic Differentiated Thyroid Cancer: Balancing Efficacy and Adverse Events.

Mangu Srinivas Bharadwaj, Sanjana Ballal, Chandrasekhar Bal

|Dec 05, 2023
Impact of radioiodine therapy on recurrence and survival outcomes in intermediate-risk papillary thyroid carcinoma -A systematic review and meta-analysis.

Kunal Ramesh Chandekar, Swayamjeet Satapathy, Chandrasekhar Bal

|Nov 06, 2023
Therapeutic potential of [<sup>177</sup>Lu]Lu-DOTAGA-FAPi dimers in metastatic breast cancer patients with limited treatment options: efficacy and safety assessment.

Madhav P Yadav, Sanjana Ballal, Marcel Martin

Pageof 3

Frequent Collaborators

2 joint publications

Swayamjeet Satapathy

1 joint publications

Alpesh Goyal

1 joint publications

Viveka P Jyotsna

Frequent Collaborators

2 joint publications

Swayamjeet Satapathy

1 joint publications

Alpesh Goyal

1 joint publications

Viveka P Jyotsna